You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ULTRAVIST (PHARMACY BULK) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ultravist (pharmacy Bulk), and when can generic versions of Ultravist (pharmacy Bulk) launch?

Ultravist (pharmacy Bulk) is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in ULTRAVIST (PHARMACY BULK) is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ULTRAVIST (PHARMACY BULK)?
  • What are the global sales for ULTRAVIST (PHARMACY BULK)?
  • What is Average Wholesale Price for ULTRAVIST (PHARMACY BULK)?
Summary for ULTRAVIST (PHARMACY BULK)
Drug patent expirations by year for ULTRAVIST (PHARMACY BULK)
Recent Clinical Trials for ULTRAVIST (PHARMACY BULK)

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GE HealthcarePhase 4
BayerPhase 4
Guerbet/Liebel-FlarsheimPhase 4

See all ULTRAVIST (PHARMACY BULK) clinical trials

US Patents and Regulatory Information for ULTRAVIST (PHARMACY BULK)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-003 Mar 12, 2004 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-001 Sep 20, 2002 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-002 Sep 20, 2002 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ULTRAVIST (PHARMACY BULK)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-003 Mar 12, 2004 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-002 Sep 20, 2002 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-001 Sep 20, 2002 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ULTRAVIST (PHARMACY BULK)

See the table below for patents covering ULTRAVIST (PHARMACY BULK) around the world.

Country Patent Number Title Estimated Expiration
Spain 489337 ⤷  Sign Up
Spain 8107165 ⤷  Sign Up
Portugal 70915 ⤷  Sign Up
Ireland 800467 ⤷  Sign Up
Japan S55153755 TRIIODOISOPHTHALIC ACID DIAMIDE DERIVATIVE* ITS MANUFACTURE AND X RAY CONTRAST AGENT CONTAINING IT ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.